1333 related articles for article (PubMed ID: 26462471)
21. Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma.
Sabel MS; Griffith K; Sondak VK; Lowe L; Schwartz JL; Cimmino VM; Chang AE; Rees RS; Bradford CR; Johnson TM
J Am Coll Surg; 2005 Jul; 201(1):37-47. PubMed ID: 15978442
[TBL] [Abstract][Full Text] [Related]
22. Do micromorphometric features of metastatic deposits within sentinel nodes predict nonsentinel lymph node involvement in melanoma?
Frankel TL; Griffith KA; Lowe L; Wong SL; Bichakjian CK; Chang AE; Cimmino VM; Bradford CR; Rees RS; Johnson TM; Sabel MS
Ann Surg Oncol; 2008 Sep; 15(9):2403-11. PubMed ID: 18626721
[TBL] [Abstract][Full Text] [Related]
23. Validation of a scoring system to predict non-sentinel lymph node metastasis in melanoma.
Cadili A; McKinnon G; Wright F; Hanna W; Macintosh E; Abhari Z; Dabbs K
J Surg Oncol; 2010 Mar; 101(3):191-4. PubMed ID: 20039281
[TBL] [Abstract][Full Text] [Related]
24. Sentinel lymph nodes containing very small (<0.1 mm) deposits of metastatic melanoma cannot be safely regarded as tumor-negative.
Murali R; DeSilva C; McCarthy SW; Thompson JF; Scolyer RA
Ann Surg Oncol; 2012 Apr; 19(4):1089-99. PubMed ID: 22271204
[TBL] [Abstract][Full Text] [Related]
25. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
[TBL] [Abstract][Full Text] [Related]
26. Is complete lymph node dissection after a positive sentinel lymph node biopsy for cutaneous melanoma always necessary? A meta-analysis.
Nagaraja V; Eslick GD
Eur J Surg Oncol; 2013 Jul; 39(7):669-80. PubMed ID: 23571104
[TBL] [Abstract][Full Text] [Related]
27. Completion Lymph Node Dissection Based on Risk of Nonsentinel Metastasis in Cutaneous Melanoma of the Head and Neck.
Fritsch VA; Cunningham JE; Lentsch EJ
Otolaryngol Head Neck Surg; 2016 Jan; 154(1):94-103. PubMed ID: 26399717
[TBL] [Abstract][Full Text] [Related]
28. In transit/local recurrences in melanoma patients after sentinel node biopsy and therapeutic lymph node dissection.
Rutkowski P; Nowecki ZI; Zurawski Z; Dziewirski W; Nasierowska-Guttmejer A; Switaj T; Ruka W
Eur J Cancer; 2006 Jan; 42(2):159-64. PubMed ID: 16324835
[TBL] [Abstract][Full Text] [Related]
29. Diversity of stage III melanoma in the era of sentinel lymph node biopsy.
Egger ME; Callender GG; McMasters KM; Ross MI; Martin RC; Edwards MJ; Urist MM; Noyes RD; Sussman JJ; Reintgen DS; Stromberg AJ; Scoggins CR
Ann Surg Oncol; 2013 Mar; 20(3):956-63. PubMed ID: 23064795
[TBL] [Abstract][Full Text] [Related]
30. Positive nonsentinel node status predicts mortality in patients with cutaneous melanoma.
Ariyan C; Brady MS; Gönen M; Busam K; Coit D
Ann Surg Oncol; 2009 Jan; 16(1):186-90. PubMed ID: 18979135
[TBL] [Abstract][Full Text] [Related]
31. Is head and neck melanoma different from trunk and extremity melanomas with respect to sentinel lymph node status and clinical outcome?
Fadaki N; Li R; Parrett B; Sanders G; Thummala S; Martineau L; Cardona-Huerta S; Miranda S; Cheng ST; Miller JR; Singer M; Cleaver JE; Kashani-Sabet M; Leong SP
Ann Surg Oncol; 2013 Sep; 20(9):3089-97. PubMed ID: 23649930
[TBL] [Abstract][Full Text] [Related]
32. Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.
Murali R; Haydu LE; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Thompson JF; Scolyer RA
Ann Surg; 2012 Jan; 255(1):128-33. PubMed ID: 21975320
[TBL] [Abstract][Full Text] [Related]
33. Observation after a positive sentinel lymph node biopsy in patients with melanoma.
Bamboat ZM; Konstantinidis IT; Kuk D; Ariyan CE; Brady MS; Coit DG
Ann Surg Oncol; 2014 Sep; 21(9):3117-23. PubMed ID: 24833100
[TBL] [Abstract][Full Text] [Related]
34. [Sentinel lymph node dissection in patients with malignant melanoma. Diagnostic and therapeutic standards].
Arens A; Osinga J; Schwipper V; Schober O; Tilkorn H; Liebau J
Chirurg; 2003 Jul; 74(7):665-70. PubMed ID: 12883795
[TBL] [Abstract][Full Text] [Related]
35. Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection.
Essner R; Scheri R; Kavanagh M; Torisu-Itakura H; Wanek LA; Morton DL
Arch Surg; 2006 Sep; 141(9):877-82; discussion 882-4. PubMed ID: 16983031
[TBL] [Abstract][Full Text] [Related]
36. Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?
Mays MP; Martin RC; Burton A; Ginter B; Edwards MJ; Reintgen DS; Ross MI; Urist MM; Stromberg AJ; McMasters KM; Scoggins CR
Cancer; 2010 Mar; 116(6):1535-44. PubMed ID: 20108306
[TBL] [Abstract][Full Text] [Related]
37. Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker.
Callender GG; Egger ME; Burton AL; Scoggins CR; Ross MI; Stromberg AJ; Hagendoorn L; Martin RC; McMasters KM
Am J Surg; 2011 Dec; 202(6):659-64; discussion 664-5. PubMed ID: 22137134
[TBL] [Abstract][Full Text] [Related]
38. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.
Wat H; Senthilselvan A; Salopek TG
J Am Acad Dermatol; 2016 Jan; 74(1):94-101. PubMed ID: 26542815
[TBL] [Abstract][Full Text] [Related]
39. International multi-institutional management and outcome of melanoma patients with positive sentinel lymph nodes in more than one nodal basin.
Melstrom LG; Taylor E; Kuk D; Frankel TL; Panageas K; Haydu L; Sabel MS; Thompson JF; Ariyan C; Coit DG; Brady MS
Ann Surg Oncol; 2014 Dec; 21(13):4324-9. PubMed ID: 24962937
[TBL] [Abstract][Full Text] [Related]
40. Sentinel lymph node biopsy in patients with primary cutaneous melanoma: study of 455 cases.
Landi G; Polverelli M; Moscatelli G; Morelli R; Landi C; Fiscelli O; Erbazzi A
J Eur Acad Dermatol Venereol; 2000 Jan; 14(1):35-45. PubMed ID: 10877250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]